Zobrazeno 1 - 10
of 953
pro vyhledávání: '"Peter Marti"'
Autor:
Mariell Rivedal, Yngvar Lunde Haaskjold, Øystein Eikrem, Rune Bjørneklett, Hans Peter Marti, Thomas Knoop
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Despite several clinical trials, the use of corticosteroid therapy for treating immunoglobulin A nephropathy (IgAN) remains controversial. We aimed to describe the use of corticosteroid therapy combined with supportive therapy in
Externí odkaz:
https://doaj.org/article/824b5472344a465098883508634bfa13
Autor:
Hassan Osman Alhassan Elsaid, Mariell Rivedal, Eleni Skandalou, Einar Svarstad, Camilla Tøndel, Even Birkeland, Øystein Eikrem, Janka Babickova, Hans-Peter Marti, Jessica Furriol
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Fabry disease (FD) is a rare lysosomal storage disorder caused by mutations in the GLA gene, resulting in reduced or lack of α-galactosidase A activity. This results in the accumulation of globotriaosylceramide (Gb3) and other gl
Externí odkaz:
https://doaj.org/article/4ff8c0c1e6f84277b262dad7adbc6a2e
Autor:
Anne Kipp, Hans-Peter Marti, Janka Babickova, Sigrid Nakken, Sabine Leh, Thea A. S. Halden, Trond Jenssen, Bjørn Egil Vikse, Anders Åsberg, Giulio Spagnoli, Jessica Furriol
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-15 (2023)
Abstract Background Diabetes mellitus (DM), either preexisting or developing after transplantation, remains a crucial clinical problem in kidney transplantation. To obtain insights into the molecular mechanisms underlying PTDM development and early g
Externí odkaz:
https://doaj.org/article/df15af6c0222407f83ce8558b2e5a24e
Autor:
Jakob E. Brune, Michael Dickenmann, Daniel Sidler, Laura N. Walti, Déla Golshayan, Oriol Manuel, Fadi Haidar, Dionysios Neofytos, Aurelia Schnyder, Katia Boggian, Thomas F. Mueller, Thomas Schachtner, Nina Khanna, Stefan Schaub, Caroline Wehmeier, the Swiss Transplant Cohort Study, Patrizia Amico, John-David Aubert, Adrian Bachofner, Vanessa Banz, Sonja Beckmann, Guido Beldi, Christoph Berger, Ekaterine Berishvili, Annalisa Berzigotti, Pierre-Yves Bochud, Sanda Branca, Heiner Bucher, Anne Cairoli, Emmanuelle Catana, Yves Chalandon, Sabina De Geest, Sophie De Seigneux, Joëlle Lynn Dreifuss, Michel Duchosal, Thomas Fehr, Sylvie Ferrari-Lacraz, Jaromil Frossard, Christian Garzoni, Nicolas Goossens, Jörg Halter, Dominik Heim, Christoph Hess, Sven Hillinger, Hans Hirsch, Patricia Hirt, Linard Hoessly, Günther Hofbauer, Uyen Huynh-Do, Franz Immer, Michael Koller, Andreas Kremer, Christian Kuhn, Bettina Laesser, Frédéric Lamoth, Roger Lehmann, Alexander Leichtle, Hans-Peter Marti, Michele Martinelli, Valérie McLin, Katell Mellac, Aurélia Merçay, Karin Mettler, Nicolas Müller, Ulrike Müller-Arndt, Beat Müllhaupt, Mirjam Nägeli, Graziano Oldani, Manuel Pascual, Jakob Passweg, Rosemarie Pazeller, Klara Posfay-Barbe, David Reineke, Juliane Rick, Anne Rosselet, Simona Rossi, Rössler, Silvia Rothlin, Frank Ruschitzka, Alexandra Scherrer, Dominik Schneidawind, Macé Schuurmans, Simon Schwab, Thierry Sengstag, Federico Simonetta, Jürg Steiger, Guido Stirniman, Ueli Stürzinger, Christian Van Delden, Jean-Pierre Venetz, Jean Villard, Julien Vionnet, Madeleine Wick, Markus Wilhlem, Patrick Yerly
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundEnterobacterales are often responsible for urinary tract infection (UTI) in kidney transplant recipients. Among these, Escherichia coli or Klebsiella species producing extended-spectrum beta-lactamase (ESBL) are emerging. However, there are
Externí odkaz:
https://doaj.org/article/8a2807b2ba0b4fa9a10786acd1fc2ce2
Autor:
Bjørn Steinar Lillås, Camilla Tøndel, Toralf Melsom, Bjørn Odvar Eriksen, Hans-Peter Marti, Bjørn Egil Vikse
Publikováno v:
Kidney International Reports, Vol 8, Iss 5, Pp 1034-1042 (2023)
Introduction: Renal functional response (RFR) is the acute increase in glomerular filtration rate (GFR) after a protein load. Low RFR is a marker of single nephron hyperfiltration. Low birth weight (LBW) is associated with reduced number of nephrons,
Externí odkaz:
https://doaj.org/article/cdb11320672b40778527b4838cad00cc
Autor:
Ole Petter Nordbø, Lea Landolt, Øystein Eikrem, Andreas Scherer, Sabine Leh, Jessica Furriol, Terje Apeland, Piotr Mydel, Hans‐Peter Marti
Publikováno v:
Physiological Reports, Vol 11, Iss 19, Pp n/a-n/a (2023)
Abstract Hypertensive nephrosclerosis (HN) and Type 2 diabetic nephropathy (T2DN) are the leading causes of chronic kidney disease (CKD). To explore shared pathogenetic mechanisms, we analyzed transcriptomes of kidney biopsies from patients with HN o
Externí odkaz:
https://doaj.org/article/f2b04b1557c248e98bfb3675c6a055b6
Autor:
Klaus-Dieter Herbst
Publikováno v:
Erhard Weigel (1625-1699) und die Wissenschaften
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8b3a0ad7897de9485d9cbb113a0a7ae
https://doi.org/10.3726/978-3-653-02154-7/5
https://doi.org/10.3726/978-3-653-02154-7/5
Autor:
Iselin Vildmyren, Åge Oterhals, Sabine Leh, Tor Andreas Samuelsen, Alfred Halstensen, Hans-Peter Marti, Oddrun Anita Gudbrandsen
Publikováno v:
Food & Nutrition Research, Vol 66, Pp 1-11 (2022)
Background: Documentation of health effects of residuals after fish filleting may motivate both consumers and producers to increase the use of this under-utilised protein source. Objectives: The primary objective of the present study was to investiga
Externí odkaz:
https://doaj.org/article/f6c7551947054d60b1849a9282cca923
Autor:
Philipp Strauss, Mariell Rivedal, Andreas Scherer, Øystein Eikrem, Sigrid Nakken, Christian Beisland, Leif Bostad, Arnar Flatberg, Eleni Skandalou, Vidar Beisvåg, Jessica Furriol, Hans-Peter Marti
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a key clinical issue. From a cohort of adult ccRCC patients
Externí odkaz:
https://doaj.org/article/4eeaf6c69c79445dafaf83fb89e0844a
Autor:
Fabian Braun, Ahmed Abed, Dominik Sellung, Manuel Rogg, Mathias Woidy, Oysten Eikrem, Nicola Wanner, Jessica Gambardella, Sandra D. Laufer, Fabian Haas, Milagros N. Wong, Bernhard Dumoulin, Paula Rischke, Anne Mühlig, Wiebke Sachs, Katharina von Cossel, Kristina Schulz, Nicole Muschol, Sören W. Gersting, Ania C. Muntau, Oliver Kretz, Oliver Hahn, Markus M. Rinschen, Michael Mauer, Tillmann Bork, Florian Grahammer, Wei Liang, Thorsten Eierhoff, Winfried Römer, Arne Hansen, Catherine Meyer-Schwesinger, Guido Iaccarino, Camilla Tøndel, Hans-Peter Marti, Behzad Najafian, Victor G. Puelles, Christoph Schell, Tobias B. Huber
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 11 (2023)
Current therapies for Fabry disease are based on reversing intracellular accumulation of globotriaosylceramide (Gb3) by enzyme replacement therapy (ERT) or chaperone-mediated stabilization of the defective enzyme, thereby alleviating lysosomal dysfun
Externí odkaz:
https://doaj.org/article/c82d0427278d4ae092a98644e9de535c